UNC Lineberger Comprehensive Cancer Center member Jim Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine and director of clinical cancer genetics, has co-authored a commentary on proposed US Food and Drug Administration (FDA) regulation of genetic testing in the Journal of the American Medical Association (JAMA).
Deborah Mayer, Ph.D., R.N., AOCN, FAAN, Professor at the School of Nursing, Director of Cancer Survivorship at UNC Lineberger, is a national pioneer on research in cancer survivorship. Her work sheds light on the best ways to monitor and manage care for cancer survivors long after diagnosis and treatment. She is a staunch advocate for serving patients' needs and the importance of good communication.
UNC Lineberger Comprehensive Cancer Center hosted the Kidney Cancer Association Patient and Survivor Conference at the William & Ida Friday Center for Continuing Education on Saturday, December 13, 2014. Attendees from New Jersey, Maryland, West Virginia, Virginia, South Carolina and North Carolina gathered to hear presentations on topics such as managing treatment, new therapies and navigating the health care system.
Chad Pecot, MD, assistant professor in hematology and oncology, has received a Mentored Research Scholar Award in Applied and Clinical Research from the American Cancer Society (ACS). Dr. Pecot is one of only two recipients in the United States to receive the award.
The UNC Cancer Pro Bono Project allows law students, working under the supervision of volunteer attorneys, to draw up advance directives for cancer patients, for free. Originally designed as a joint program with Duke, Carolina’s student-run program has grown so much that it operates independently now, with the help of Legal Aid of North Carolina Inc. and about 35 volunteer attorneys.
UNC Lineberger members Lisa Carey, MD, Chuck Perou, PhD, Hyman Muss, MD, Carey Anders, MD, and Katherine Hoadley, PhD will present at leading breast cancer research symposium.
AnnMarie Walton, MPH, RN, OCN, CHES, PhD candidate, an oncology nurse at the N.C. Cancer Hospital, who has made extraordinary efforts to improve the health and lives of agricultural workers and health care providers has been recognized as one of the 10 recipients of the new Breakthrough Leaders in Nursing award created by the Future of Nursing: Campaign for Action, a joint initiative of AARP and the Robert Wood Johnson Foundation.
Several UNC Lineberger members and UNC School of Medicine faculty presented at the American Society of Hematology (ASH) Annual Meeting in San Francisco last week. With more than 15,000 members from nearly 100 countries, ASH is the world's largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases. The 56th ASH Annual Meeting & Exposition is the premier event in malignant and non-malignant hematology.
Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, has been named to the American Society of Clinical Oncology (ASCO) Nominating Committee. An ASCO member since 1997, Carey will serve a three-year term on the committee.
Since 2009, Elizabeth Stewart has honored the memory of her daughter Charli’ Ramsey with an annual hat drive for pediatric oncology patients and bone marrow transplant patients at UNC Lineberger. Charli’ was treated for leukemia at UNC before she passed away in 2001 at the age of nine. Over the years, the effort has expanded to include not just hats but pillowcases, blankets and scarves: all items that provide comfort and a measure of happiness to patients in treatment.
UNC Lineberger members and UNC School of Medicine researchers have found for the first time a biochemical mechanism that could be a cause of “chemo brain” – the neurological side effects such as memory loss, confusion, difficulty thinking, and trouble concentrating that many cancer patients experience while on chemotherapy to treat tumors in other parts of the body.
Matthew G. Ewend, MD, FACS, Van L. Weatherspoon, Jr. Eminent Distinguished Professor and Chair, UNC Department of Neurosurgery and UNC Lineberger member, has been awarded this year’s H. Fleming Fuller Award.
Congratulations to nurse practitioner Mary Dunn and clinical nurse Lauren Terzo for winning the 2014 Oncology Nursing Excellence Award and to financial counselor Cynthia Moody and administrative support supervisor Christine Nadel, winners of the 2014 Clinical Services Excellence Award.
Over 100 people had the opportunity to learn about cancer, aging and resilience from UNC cancer care experts on Friday, November 14, at Cancer Care and Older Adults: A Public Forum hosted by UNC Lineberger Comprehensive Cancer Center.
UNC Lineberger researchers and colleagues at The University of Texas MD Anderson Cancer Center have developed a new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer. The approach, led by Chad Pecot, MD, an assistant professor of medicine at UNC, offers another route to attack KRAS, which has proven to be an elusive and frustrating target for drug developers.
Stergios Moschos, MD, associate professor and UNC Lineberger Comprehensive Cancer Center member, is among 11 physicians from across the country to receive the National Cancer Institute (NCI) 2014 Cancer Clinical Investigator Team Leadership Award.
The proportion of adolescent girls receiving human papillomavirus (HPV) vaccines was much lower in states with higher rates of cervical cancer incidence and mortality, according to data presented by doctoral student Jennifer Moss at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 9–12.
The 12th annual Avon Walk for Breast Cancer season concluded with the Charlotte Walk on October 26, raising $1.4 million to accelerate breast cancer research and improve access to screening, diagnosis, treatment and education. Hazel Nichols, PhD, assistant professor epidemiology at UNC Gillings School of Global Public Health is leading one of five teams in the Carolinas awarded a grant of $200,000 to support a study that will analyze data from 18 ongoing studies on pregnancy-associated breast cancer.
Chad Pecot, MD, assistant professor in hematology and oncology, has received a V Scholar Award from the The V Foundation for Cancer Research. Dr. Pecot is one of 20 recipients in the United States to receive the two-year $200,000 award.
Targeting CC-Chemokine Receptor 7 (CCR7) with fully human anti-CCR7 antibodies for the prevention of graft-versus-host disease.
The UNC Department of Urology is once again participating in Movember, a global mustache-growing fundraising campaign meant to spark conversation and raise funds for men’s health programs.
Over 5,000 cancer patients are now enrolled in the UNC Health Registry, an initiative funded by the University Cancer Research Fund established to better understand the long-term consequences of cancer, which affect many North Carolinians. This milestone hits the half-way mark of the 10,000 enrollment goal.
UNC Cancer Care thoracic oncologists joined the Lung Cancer Initiative's Raleigh LUNGe Forward 5K Run, Walk & Rally on November 1, 2014 in Raleigh, NC.
The V Foundation awards $600,000 grant to UNC Lineberger to track kinase activity in head and neck, lung and esophageal cancers.
When Stephen Frye completed his Ph.D. in chemistry at Carolina in 1987, he set out to make a difference.